Biomarkers and Right Ventricular Dysfunction
- PMID: 31733676
- PMCID: PMC9982435
- DOI: 10.1016/j.ccc.2019.08.011
Biomarkers and Right Ventricular Dysfunction
Abstract
Right ventricular failure is common in critically ill patients, as it frequently results from pulmonary embolism or pulmonary hypertension, and can complicate sepsis and the acute respiratory distress syndrome. Right ventricular dysfunction can be challenging to manage and is associated with poor outcomes in this wide array of disease. Laboratory biomarkers are rapid, noninvasive, accurate, and widely available and thus are useful in the diagnosis and management of right ventricular dysfunction in the critically ill patient. This article discusses the pathophysiology of right ventricular failure and reviews the applications of commonly used biomarkers in right ventricular dysfunction in critical care.
Keywords: Biomarkers; Brain natriuretic peptide; Pulmonary embolism; Pulmonary hypertension; Right ventricular dysfunction; Troponin.
Copyright © 2019 Elsevier Inc. All rights reserved.
Figures
References
-
- Konstam M.A., Kiernan M.S., Bernstein D., et al. Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association. Circulation. 2018;137(20):e578–e622. - PubMed
-
- Beckman M.G., Hooper W.C., Critchley S.E., et al. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(4):S495–S501. - PubMed
-
- Zochios V., Parhar K., Tunnicliffe W., et al. The right ventricle in ARDS. Chest. 2017;152(1):181–193. - PubMed
-
- Zapol W.M., Snider M.T. Pulmonary hypertension in severe acute respiratory failure. N Engl J Med. 1977;296(9):476–480. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
